137 related articles for article (PubMed ID: 36075132)
81. pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer.
Zhu SW; Ye M; Ma X; Wu ZZ; Wan SC; Yang SC; Li H; Xu Z; Sun ZJ
Acta Biomater; 2022 Dec; 154():497-509. PubMed ID: 36367476
[TBL] [Abstract][Full Text] [Related]
82. Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer.
Song L; Hao Y; Wang C; Han Y; Zhu Y; Feng L; Miao L; Liu Z
J Control Release; 2022 Oct; 350():922-932. PubMed ID: 36108810
[TBL] [Abstract][Full Text] [Related]
83. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
84. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
85. Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy.
Wang K; Jiang M; Zhou J; Liu Y; Zong Q; Yuan Y
ACS Nano; 2022 Jan; 16(1):721-735. PubMed ID: 34978422
[TBL] [Abstract][Full Text] [Related]
86. Nanoscale CaO
Wang Y; He X; Zhou C; Bai Y; Li T; Liu J; Ju S; Wang C; Xiang G; Xiong B
Acta Biomater; 2022 Dec; 154():536-548. PubMed ID: 36241014
[TBL] [Abstract][Full Text] [Related]
87. Perfluorocarbon-Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer.
Song G; Liang C; Yi X; Zhao Q; Cheng L; Yang K; Liu Z
Adv Mater; 2016 Apr; 28(14):2716-23. PubMed ID: 26848553
[TBL] [Abstract][Full Text] [Related]
88. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance.
Belisario DC; Kopecka J; Pasino M; Akman M; De Smaele E; Donadelli M; Riganti C
Cells; 2020 Dec; 9(12):. PubMed ID: 33291643
[TBL] [Abstract][Full Text] [Related]
89. Nanozyme-Incorporated Biodegradable Bismuth Mesoporous Radiosensitizer for Tumor Microenvironment-Modulated Hypoxic Tumor Thermoradiotherapy.
Zhang J; Liu Y; Wang X; Du J; Song K; Li B; Chang H; Ouyang R; Miao Y; Sun Y; Li Y
ACS Appl Mater Interfaces; 2020 Dec; 12(52):57768-57781. PubMed ID: 33326213
[TBL] [Abstract][Full Text] [Related]
90. Au-Hemoglobin Loaded Platelet Alleviating Tumor Hypoxia and Enhancing the Radiotherapy Effect with Low-Dose X-ray.
Xia D; Hang D; Li Y; Jiang W; Zhu J; Ding Y; Gu H; Hu Y
ACS Nano; 2020 Nov; 14(11):15654-15668. PubMed ID: 33108152
[TBL] [Abstract][Full Text] [Related]
91. A Cascade Nanozyme with Amplified Sonodynamic Therapeutic Effects through Comodulation of Hypoxia and Immunosuppression against Cancer.
Tao N; Li H; Deng L; Zhao S; Ouyang J; Wen M; Chen W; Zeng K; Wei C; Liu YN
ACS Nano; 2022 Jan; 16(1):485-501. PubMed ID: 34962762
[TBL] [Abstract][Full Text] [Related]
92. Tumor acidity, chemoresistance and proton pump inhibitors.
De Milito A; Fais S
Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
[TBL] [Abstract][Full Text] [Related]
93. Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy.
Huang SY; Yeh NT; Wang TH; Hsu TC; Chin HY; Tzang BS; Chiang WH
Int J Biol Macromol; 2023 Feb; 227():925-937. PubMed ID: 36563808
[TBL] [Abstract][Full Text] [Related]
94. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
95. Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors.
Zhou J; Xue C; Hou Y; Li M; Hu Y; Chen Q; Li Y; Li K; Song G; Cai K; Luo Z
Biomaterials; 2019 Mar; 197():129-145. PubMed ID: 30641264
[TBL] [Abstract][Full Text] [Related]
96. CaCO
Dong Z; Feng L; Zhu W; Sun X; Gao M; Zhao H; Chao Y; Liu Z
Biomaterials; 2016 Dec; 110():60-70. PubMed ID: 27710833
[TBL] [Abstract][Full Text] [Related]
97. Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy.
Wang W; Cheng Y; Yu P; Wang H; Zhang Y; Xu H; Ye Q; Yuan A; Hu Y; Wu J
Nat Commun; 2019 Apr; 10(1):1580. PubMed ID: 30952842
[TBL] [Abstract][Full Text] [Related]
98. Perfluorocarbon emulsion therapy attenuates pneumococcal infection in sickle cell mice.
Helmi N; Andrew PW; Pandya HC
J Infect Dis; 2015 May; 211(10):1677-85. PubMed ID: 25429101
[TBL] [Abstract][Full Text] [Related]
99. Multifunctional biomaterials that modulate oxygen levels in the tumor microenvironment.
Hu J; Guan Z; Chen J
Cancer Lett; 2021 Aug; 521():39-49. PubMed ID: 34419500
[TBL] [Abstract][Full Text] [Related]
100. Oxygen switches: Refueling for cancer radiotherapy.
Li X; Wang H; Li Z; Tao F; Wu J; Guan W; Liu S
Front Oncol; 2022; 12():1085432. PubMed ID: 36873299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
